Physician profile
Jonathan P Mannas
NPI 1740414895
$729.25
in general payments reported to CMS, 2019-2025
13 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.70 · 2021: $59.87 · 2022: $201 · 2023: $79.79 · 2024: $125 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $141.90 | 2020-2025 | Teligen |
| Providence Medical Technology, INC. | $117.32 | 2025 | |
| Zap Surgical Systems, INC. | $101.65 | 2022 | |
| Zimmer Biomet Holdings, INC. | $60.20 | 2023-2024 | Neuro Plating System, Neuro Plating System |
| Aesculap, INC. | $59.87 | 2021 | |
| Silk Road Medical, INC. | $46.63 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Integra Lifesciences Corporation | $46.40 | 2024 | Codman Certas, Cusa Clarity, Codman Hakim |
| Globus Medical, INC. | $42.33 | 2025 | Harvest |
| Spinal Elements, INC. | $28.03 | 2024 | |
| Medtronic, INC. | $23.83 | 2024 | Concertotm |
| Boston Scientific Corporation | $22.43 | 2025 | General - Therapies |
| Abbott Laboratories | $22.42 | 2023 | Proclaim |
| Stryker Corporation | $16.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mannas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.